[Research](/research) / DrugShortagePulse

# FDA Drug Shortages & Manufacturer Discontinuations by Company: 2026 statistics from 353 public records

**The most common therapeutic category is Anesthesia: 73 of 353 records (20.7%) (as of 2026-11-04; source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)).**

Data as of 2026-11-04 · Compiled by Zalwin from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) Copy citation

Work with the records behind these figures: all 353 DrugShortagePulse records with source links, as one CSV.

Download all 353 records (CSV) — $4.99 → [Free sample: 3 records (CSV)](/v1/verticals/drugshortagepulse/records.csv) [Search the records free →](/v/drugshortagepulse?channel=pseo#vt-out)

Double opt-in: we send one confirmation email when digests start; nothing else until you confirm. One-click unsubscribe.

## Key findings

- Zalwin's DrugShortagePulse dataset holds 353 DrugShortagePulse records dated 2026-05-01 to 2026-11-03 (as of 2026-11-04; source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)). [#](#finding-1)
- The most common therapeutic category is Anesthesia: 73 of 353 records (20.7%) (as of 2026-11-04; source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)). [#](#finding-2)
- Across 353 records with a stated amount, the total is 1,307 and the median is 3; the largest is 24 (Sanofi-Aventis U.S. LLC) (as of 2026-11-04; source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)). [#](#finding-3)
- The top 10% of records by amount (35 of 353) account for 31.8% of the total (as of 2026-11-04; source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)). [#](#finding-4)
- 241 of 353 records (68.3%) are dated within the 30 days before 2026-11-04 (source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)). [#](#finding-5)

## DrugShortagePulse records by therapeutic category

| Group | Records | Share |
|---|---|---|
| Anesthesia | 73 | 20.7% |
| Cardiovascular | 35 | 9.9% |
| Endocrinology/Metabolism | 33 | 9.3% |
| Psychiatry | 32 | 9.1% |
| Oncology | 32 | 9.1% |
| Analgesia/Addiction | 32 | 9.1% |
| Anti-Infective | 30 | 8.5% |
| Neurology | 15 | 4.2% |
| Other | 12 | 3.4% |
| Rheumatology | 10 | 2.8% |
| Hematology | 9 | 2.5% |
| Gastroenterology | 9 | 2.5% |
| Dermatology | 8 | 2.3% |
| Antiviral | 7 | 2.0% |
| Pulmonary/Allergy | 5 | 1.4% |

## Methodology and data provenance

- Sample: 353 public records dated 2026-05-01 to 2026-11-03; illustrative samples excluded.

- Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list). Refreshed automatically about every 24 hours; figures above are as of 2026-11-04.

- Shares are of all records in the dataset; totals and medians use only records with a stated amount.

- Organization-level data only. Informational; verify individual records at the official source.

### Cite this study

Zalwin Research, "DrugShortagePulse statistics" (data as of 2026-11-04), https://zalwin.com/research/drugshortagepulse

Copy citation

[Search the DrugShortagePulse records](/v/drugshortagepulse) [Browse by state and category](/hub/drugshortagepulse)